tradmap

HOWL Earnings Werewolf Therapeutics, Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$28 -$14 $0 2020 2021 2022 2023 2024 2025
EPS
Net income (annual)
-$71M -$35M $0 2020 2021 2022 2023 2024 2025
Net income
Return on equity (annual)
-245% -108% 29% 0% 2020 2021 2022 2023 2024 2025
ROE

Quarterly results

Diluted EPS (quarterly)
-$1 -$1 $0 Q3 '22 Q2 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26
EPS
Net income (quarterly)
-$20M -$8M $4M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income
Return on equity (quarterly)
-111% -44% 23% 0% Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
ROE

Reported EPS history

1–26 of 26
Q2 20262026-06-30-0.202026-07-3110-Q
Q1 20262026-03-31-0.282026-05-0710-Q
FY 20252025-12-31-1.332026-03-2710-K
Q3 20252025-09-30-1.162025-11-0410-Q
Q2 20262025-06-30-0.802026-07-3110-Q
Q1 20262025-03-31-0.402026-05-0710-Q
FY 20252024-12-31-1.632026-03-2710-K
Q3 20252024-09-30-1.192025-11-0410-Q
Q2 20252024-06-30-0.822025-08-1410-Q
Q1 20252024-03-31-0.392025-05-0810-Q
FY 20242023-12-31-1.052025-03-1110-K
Q3 20242023-09-30-0.722024-11-0710-Q
Q2 20242023-06-30-0.492024-08-0810-Q
Q1 20242023-03-31-0.342024-05-0310-Q
FY 20232022-12-31-1.862024-03-0710-K
Q3 20232022-09-30-1.482023-11-1410-Q
Q2 20232022-06-30-1.092023-08-1010-Q
Q1 20232022-03-31-0.562023-05-1110-Q
FY 20222021-12-31-10.942023-03-2310-K
Q3 20222021-09-30-11.892022-11-1010-Q
Q2 20222021-06-30-17.862022-08-1110-Q
Q1 20222021-03-31-83.362022-05-1010-Q
FY 20212020-12-31-28.082022-03-2410-K
Q3 20212020-09-30-8.032021-11-1010-Q
Q2 20212020-06-30-1.802021-08-1210-Q
Q1 20212020-03-31-4.582021-06-1010-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.